|
Volumn 42, Issue , 2004, Pages 323-351
|
Ruthenium anticancer drugs.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DIMETHYL SULFOXIDE;
DRUG DERIVATIVE;
IMIDAZOLIUM BIS(IMIDAZOLE)DIMETHYLSULFOXIDEIMIDAZOTETRACHLORORUTHENATE(III);
IMIDAZOLIUM-BIS(IMIDAZOLE)DIMETHYLSULFOXIDEIMIDAZOTETRACHLORORUTHENATE(III);
MITOGEN ACTIVATED PROTEIN KINASE;
ORGANOMETALLIC COMPOUND;
RUTHENIUM DERIVATIVE;
CANCER INVASION;
CELL CYCLE;
CHEMISTRY;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
METASTASIS;
NEOPLASM;
PATHOLOGY;
REVIEW;
SYNTHESIS;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
DIMETHYL SULFOXIDE;
HUMANS;
MITOGEN-ACTIVATED PROTEIN KINASES;
NEOPLASM INVASIVENESS;
NEOPLASM METASTASIS;
NEOPLASMS;
ORGANOMETALLIC COMPOUNDS;
RUTHENIUM COMPOUNDS;
|
EID: 3042744837
PISSN: 01615149
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (135)
|
References (70)
|